V Smith1, L Verhey, C F Serago. 1. Department of Radiation Oncology, University of California, San Francisco 94143-0226, USA. smith@radonc4.ucsf.edu
Abstract
PURPOSE: The relative efficacy of Gamma Knife, Linac, and Proton treatment modalities for stereotactic radiosurgery (SRS) was investigated on the basis of normal tissue complication probability (NTCP) and tumor control probability (TCP), calculated for representative test cases. METHODS AND MATERIALS: Five radiosurgery patient cases were selected to cover a range of treatment-planning situations from small spherical volumes to large irregular volumes. A target volume consisting of contours drawn on CT transverse slices was prepared for each case. Plans were developed using the three treatment modalities for each case, with the objective of encompassing the target as closely as possible with a prescription isodose line and minimizing dose to normal tissue, within the constraints of current clinical practice. Dose-volume histograms (DVH) were calculated for the target and for normal tissue, and these histograms were used to calculate NTCP and TCP values for each plan. RESULTS AND CONCLUSIONS: Differences in NTCP and TCP values were found to depend on treatment modality, size, shape, and location of the target, the amount of effort devoted to treatment planning, and the complexity of the plan.
PURPOSE: The relative efficacy of Gamma Knife, Linac, and Proton treatment modalities for stereotactic radiosurgery (SRS) was investigated on the basis of normal tissue complication probability (NTCP) and tumor control probability (TCP), calculated for representative test cases. METHODS AND MATERIALS: Five radiosurgery patient cases were selected to cover a range of treatment-planning situations from small spherical volumes to large irregular volumes. A target volume consisting of contours drawn on CT transverse slices was prepared for each case. Plans were developed using the three treatment modalities for each case, with the objective of encompassing the target as closely as possible with a prescription isodose line and minimizing dose to normal tissue, within the constraints of current clinical practice. Dose-volume histograms (DVH) were calculated for the target and for normal tissue, and these histograms were used to calculate NTCP and TCP values for each plan. RESULTS AND CONCLUSIONS: Differences in NTCP and TCP values were found to depend on treatment modality, size, shape, and location of the target, the amount of effort devoted to treatment planning, and the complexity of the plan.
Authors: J A Tanyi; E J Doss; C M Kato; D L Monaco; L ZMeng; Y Chen; C D Kubicky; C M Marquez; M Fuss Journal: Br J Radiol Date: 2012-11 Impact factor: 3.039
Authors: Anees Dhabaan; Eric Elder; Eduard Schreibmann; Ian Crocker; Walter J Curran; Nelson M Oyesiku; Hui-Kuo Shu; Tim Fox Journal: J Appl Clin Med Phys Date: 2010-06-21 Impact factor: 2.102
Authors: Rami A El Shafie; Maja Czech; Kerstin A Kessel; Daniel Habermehl; Dorothea Weber; Stefan Rieken; Nina Bougatf; Oliver Jäkel; Jürgen Debus; Stephanie E Combs Journal: Radiat Oncol Date: 2018-03-27 Impact factor: 3.481